APA

Maemondo M., Minegishi Y., Inoue A., Kobayashi K., Harada M., Okinaga S., Morikawa N., Oizumi S., Tanaka T., Isobe H., Kudoh S., Hagiwara K., Nukiwa T., Gemma A. & Gemmah A. (20130117). First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Maemondo Makoto, Minegishi Yuji, Inoue Akira, Kobayashi Kunihiko, Harada Masao, Okinaga Shoji, Morikawa Naoto, Oizumi Satoshi, Tanaka Tomoaki, Isobe Hiroshi, Kudoh Shoji, Hagiwara Koichi, Nukiwa Toshihiro, Gemma Akihiko and Gemmah Akihiko. 20130117. First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Maemondo M., Minegishi Y., Inoue A., Kobayashi K., Harada M., Okinaga S., Morikawa N., Oizumi S., Tanaka T., Isobe H., Kudoh S., Hagiwara K., Nukiwa T., Gemma A. and Gemmah A. (20130117). First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Maemondo Makoto, Minegishi Yuji, Inoue Akira, Kobayashi Kunihiko, Harada Masao, Okinaga Shoji, Morikawa Naoto, Oizumi Satoshi, Tanaka Tomoaki, Isobe Hiroshi, Kudoh Shoji, Hagiwara Koichi, Nukiwa Toshihiro, Gemma Akihiko and Gemmah Akihiko. First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20130117.